Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the full record of transactions filed by Cole Douglas G., Director. Insider active across 1 company, notably Denali Therapeutics Inc.. In total, 4 reports have been recorded. History available since 1 June 2021. The latest transaction was disclosed on 1 June 2023 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Douglas G. Cole serves as a Board Member at Denali Therapeutics Inc. He brings his expertise to the board, contributing to strategic decision-making and oversight of operations. His role is crucial in ensuring compliance and good governance within the company. Cole is committed to supporting the mission of Denali Therapeutics Inc. and promoting best practices within the organization.